Kazia Therapeutics Limited. Weighted Average Remaining Contractual Life Of Outstanding Share Options
Kazia Therapeutics Limited. (KZIA) had Weighted Average Remaining Contractual Life Of Outstanding Share Options of 2.36 Y as of 2019-06-30, per its 20-F filed 2019-10-21.
Discontinued › Notes
ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions · last filed 2019-10-21
- 2019-06-30: Weighted Average Remaining Contractual Life Of Outstanding Share Options 2.36 Y.
- 2018-06-30: Weighted Average Remaining Contractual Life Of Outstanding Share Options 2.97 Y.
- 2017-06-30: Weighted Average Remaining Contractual Life Of Outstanding Share Options 3.55 Y.
| Period end | Weighted Average Remaining Contractual Life Of Outstanding Share Options |
|---|---|
| 2019-06-30 | 2.36 Y 20-F · filed 2019-10-21 |
| 2018-06-30 | 2.97 Y 20-F · filed 2019-10-21 |
| 2017-06-30 | 3.55 Y 20-F · filed 2018-10-24 |